NCEL
NCEL
NASDAQ · Biotechnology

Newcelx Ltd

$2.63
-0.06 (-2.23%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,442.6% upside
Low Target $36.99
Average Target $40.57
High Target $64.99
Current Price $2.63
Current
$2.63
Target
$40.57
$36.99 $40.57 avg $64.99
Scenario Analysis
Bear Case
$36.99
1,306.5%
Low target
Base Case
$40.57
+1,442.6%
Avg target
Bull Case
$64.99
+2,371.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$6.48
-59.4% from high
52-Week Low
$1.83
+43.7% from low
Target vs 52W High
$40.57
+526.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%